Identification Generic Name (1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE DrugBank Accession Number DB07356 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE (DB07356) ×  Close Weight Average: 249.3519  Monoisotopic: 249.184112373  Chemical Formula C 14 H 23 N 3 O Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Dipeptidyl peptidase 4 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. Kingdom Organic compounds Super Class Organic acids and derivatives Class Carboxylic acids and derivatives Sub Class Amino acids, peptides, and analogues Direct Parent Alpha amino acid amides Alternative Parents N-acylpyrrolidines  /  Tertiary carboxylic acid amides  /  Azacyclic compounds  /  Acetylides  /  Organopnictogen compounds  /  Organic oxides  /  Monoalkylamines  /  Hydrocarbon derivatives  /  Carbonyl compounds Substituents Acetylide  /  Aliphatic heteromonocyclic compound  /  Alpha-amino acid amide  /  Amine  /  Azacycle  /  Carbonyl group  /  Carboxamide group  /  Hydrocarbon derivative  /  N-acylpyrrolidine  /  Organic nitrogen compound Molecular Framework Aliphatic heteromonocyclic compounds External Descriptors terminal acetylenic compound, N-acylpyrrolidine ( CHEBI:40697 )  Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key XYVMJMYCUZCIPB-AVGNSLFASA-N InChI InChI=1S/C14H23N3O/c1-2-11-7-8-12(9-15)17(11)14(18)13(16)10-5-3-4-6-10/h1,10-13H,3-9,15-16H2/t11-,12-,13-/m0/s1 IUPAC Name (2S)-2-amino-1-[(2S,5R)-2-(aminomethyl)-5-ethynylpyrrolidin-1-yl]-2-cyclopentylethan-1-one SMILES [H][C@](N)(C1CCCC1)C(=O)N1[C@]([H])(CN)CC[C@]1([H])C#C References General References Not Available External Links PubChem Compound 11840917 PubChem Substance 99443827 ChemSpider 10015422 ChEBI 40697 ZINC ZINC000036470911 PDBe Ligand AIA PDB Entries 2gbf Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.166 mg/mL ALOGPS logP 0.46 ALOGPS logP 0.33 Chemaxon logS -3.2 ALOGPS pKa (Strongest Basic) 9.26 Chemaxon Physiological Charge 2 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 72.35 Å 2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 70.92 m 3 ·mol -1 Chemaxon Polarizability 28.33 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9339 Blood Brain Barrier + 0.9572 Caco-2 permeable - 0.6 P-glycoprotein substrate Non-substrate 0.583 P-glycoprotein inhibitor I Non-inhibitor 0.81 P-glycoprotein inhibitor II Non-inhibitor 0.6633 Renal organic cation transporter Non-inhibitor 0.679 CYP450 2C9 substrate Non-substrate 0.8943 CYP450 2D6 substrate Non-substrate 0.644 CYP450 3A4 substrate Non-substrate 0.6612 CYP450 1A2 substrate Non-inhibitor 0.8023 CYP450 2C9 inhibitor Non-inhibitor 0.8423 CYP450 2D6 inhibitor Non-inhibitor 0.883 CYP450 2C19 inhibitor Non-inhibitor 0.7431 CYP450 3A4 inhibitor Non-inhibitor 0.8404 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.7212 Ames test Non AMES toxic 0.7636 Carcinogenicity Non-carcinogens 0.9091 Biodegradation Not ready biodegradable 0.9274 Rat acute toxicity 2.1588 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9496 hERG inhibition (predictor II) Non-inhibitor 0.809    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Dipeptidyl peptidase 4 Kind Protein Organism Humans Pharmacological action Unknown General Function Virus receptor activity Specific Function Cell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Acts as a positive regulator of T-cell coactivation, by bindi... Gene Name DPP4 Uniprot ID P27487 Uniprot Name Dipeptidyl peptidase 4 Molecular Weight 88277.935 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:20 / Updated at June 12, 2020 16:52 